URGN 最新季度财报
公布日期8/5/2026
实际每股收益(美元)-0.28
实际营收(美元)72.46M
本页面提供详细的 Urogen Pharma Ltd 财报数据,包括最新财报、下一次财报发布日期、历史数据及 Urogen Pharma Ltd 财报电话会相关新闻。
| 发布日期 | 报告期末 | 每股收益/预测值 | 营收/预测值 | 每股收益超预期幅度 % | 营收超预期幅度 % |
|---|---|---|---|---|---|
| 8/5/2026 | 06/2026 | -0.28/-0.29 | 72.46M/63.53M | 0.80% | 14.06% |
| 5/6/2026 | 03/2026 | -0.47/-0.48 | 50.96M/44.82M | 2.64% | 13.70% |
| 3/2/2026 | 12/2025 | -0.54/-0.50 | 37.84M/39.92M | -6.56% | -5.22% |
| 11/6/2025 | 09/2025 | -0.69/-0.69 | 27.48M/33.09M | -0.20% | -16.96% |
| 8/7/2025 | 06/2025 | -1.05/-0.83 | 24.21M/23.13M | -25.47% | 4.67% |
| 5/12/2025 | 03/2025 | -0.92/-0.80 | 20.25M/22.80M | -15.57% | -11.18% |
| 3/10/2025 | 12/2024 | -0.65/-0.72 | 24.57M/25.63M | 10.35% | -4.17% |
| 11/6/2024 | 09/2024 | -0.55/-0.82 | 25.20M/24.20M | 32.78% | 4.13% |